Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
82.38
-0.63 (-0.76%)
Jun 9, 2026, 1:04 PM EDT - Market open
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$1,052,165
Market Cap
6.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| PTC Therapeutics | 991 |
| Vaxcyte | 507 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Kymera Therapeutics | 253 |
APGE News
- 1 day ago - Apogee Therapeutics price target raised to $97 from $82 at RBC Capital - TheFly
- 6 days ago - Apogee Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Apogee Therapeutics to Participate in Upcoming June Conferences - GlobeNewsWire
- 12 days ago - Apogee Therapeutics moved to Neutral at Goldman Sachs - TheFly
- 13 days ago - Apogee Therapeutics price target lowered to $81 from $83 at Truist - TheFly
- 13 days ago - Apogee Therapeutics price target raised to $135 from $120 at Wedbush - TheFly
- 13 days ago - Apogee secures up to $1.3 billion from Blackstone to advance eczema drug - Reuters
- 13 days ago - Apogee Therapeutics Transcript: Study result - Transcripts